Clinical application and significance of drug delivery systems. Progestasert, an intrauterine progesterone contraceptive system
Okada, H.; Honjo, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1353-1356
1989
ISSN/ISBN: 0047-1852 PMID: 2769995 Document Number: 287420
Document emailed within 1 workday
Related Documents
Yoshikawa, H. 1989: Clinical application and significance of drug delivery systems. Cytokine Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1324-1328Iwaoka, H.; Tsuchida, H.; Makino, H.; Yoshida, S. 1989: Clinical application and significance of drug delivery systems. Insulin injection therapy of diabetes Nihon Rinsho. Japanese Journal of Clinical Medicine 47(6): 1329-1334
Fraser, I.S. 2013: Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems Contraception 87(3): 273-279
Pharriss, B.B. 1978: Clinical experience with the intrauterine progesterone contraceptive system Journal of Reproductive Medicine 20(3): 155-165
Zador, G.; Nilsson, B.A.; Nilsson, B.; Sjöberg, N.O.; Weström, L.; Wiese, J. 1976: Clinical experience with the uterine progesterone system (Progestasert R) Contraception 13(5): 559-569
Archer, D.F.; Desoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-α concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone : A possible mechanism of action of the intrauterine device Contraception (Stoneham) 59(3): 175-179
Archer, D.F.; DeSoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device Contraception 59(3): 175-179
Place, V.A.; Pharriss, B.B. 1974: Progress in the development of the Progestasert TM 65 progesterone therapeutic system for contraception Journal of Reproductive Medicine 13(2): 66-68
Volpe, A.; Botticelli, A.; Abrate, M.; Dalla Vecchia, E.; Mantovani, M.; Carani, C.; Grasso, A.; Mazza, V.; Di Renzo, G.C. 1982: An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia Maturitas 4(1): 73-79
Scarselli, G.; Mencaglia, L.; Tantini, C.; Colafranceschi, M.; Taddei, G. 1984: Hysteroscopic evaluation of intrauterine progesterone contraceptive system as a treatment for abnormal uterine bleeding Acta Europaea Fertilitatis 15(4): 279-282
Scarselli, G.; Mencaglia, L.; Tantini, C.; Colafranceschi, M.; Taddei, G. 1984: Hysteroscopic evaluation of intrauterine progesterone contraceptive system as a treatment for abnormal uterine bleeding Acta Europaea Fertilitatis 15(4): 279-282
Tsunoda, S.; Tsutsumi, Y.; Mayumi, T. 1998: Molecular design of polymer-conjugated cytokines and its application for drug delivery systems Nihon Rinsho. Japanese Journal of Clinical Medicine 56(3): 573-578
Hudson, R.; Hemphill, P.; Tillson, S.A. 1978: Preclinical evaluation of intrauterine progesterone as a contraceptive agent. I. Local contraceptive effects and their reversal Contraception 17(5): 465-474
Li, F.-Z.; Pan, X.-W. 2006: Microdialysis in mice and its application in drug delivery system Yao Xue Xue Bao 41(10): 921-926
Wildemeersch, D.; Schacht, E. 2001: Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 6(2): 93-101
Salahović, S.; Kunstelj, D. 1976: Clinical significance of organic deposits on intrauterine contraceptive devices Jugoslavenska Ginekologija i Opstetricija 16(5-6): 357-363
Farghali, H.; Kameníková, L. 2017: Targeted drug delivery system: potential application to resveratrol Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 66(2): 76-82
Kunisawa, J.; Mayumi, T. 2001: Application of novel drug delivery system, fusogenic liposome, for cancer therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(5): 577-583
Wildemeersch, D.; Schacht, E.; Wildemeersch, P. 2002: Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study Contraception 66(2): 93-99
Pfister, W.R.; Hsieh, D.S. 1990: Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations Medical Device Technology 1(6): 28-33